<?xml version="1.0" encoding="UTF-8"?>
<!--generator='jetpack-16.4'-->
<!--Jetpack_Sitemap_Buffer_News_XMLWriter-->
<?xml-stylesheet type="text/xsl" href="//nxtin.health/news-sitemap.xsl"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd">
 <url>
  <loc>https://nxtin.health/2026/11/04/international-research-award-from-rigshospitalet-goes-to-a-frontrunner-in-fetal-medicine/</loc>
  <lastmod>2026-11-04T19:01:41Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>NXTin health</news:name>
    <news:language>en</news:language>
   </news:publication>
   <news:title>International research award from Rigshospitalet goes to a frontrunner in fetal medicine</news:title>
   <news:publication_date>2026-11-04T19:01:38Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://nxtin.health/2026/11/04/bavarian-nordic-awarded-multi-year-vaccine-contract-by-uk-government/</loc>
  <lastmod>2026-11-04T18:37:26Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>NXTin health</news:name>
    <news:language>en</news:language>
   </news:publication>
   <news:title>Bavarian Nordic awarded multi-year vaccine contract by UK Government</news:title>
   <news:publication_date>2026-11-04T18:33:48Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://nxtin.health/2026/11/04/oulu-researchers-develop-treatment-to-boost-the-brains-waste-clearance/</loc>
  <lastmod>2026-11-04T18:12:52Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>NXTin health</news:name>
    <news:language>en</news:language>
   </news:publication>
   <news:title>Oulu researchers develop treatment to boost the brain&amp;#039;s waste clearance</news:title>
   <news:publication_date>2026-11-04T18:12:49Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://nxtin.health/2026/11/04/desentum-raises-e28-million-to-develop-safer-more-effective-allergen-immunotherapy/</loc>
  <lastmod>2026-11-04T17:39:30Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>NXTin health</news:name>
    <news:language>en</news:language>
   </news:publication>
   <news:title>Desentum raises €28 million to develop safer, more effective allergen immunotherapy</news:title>
   <news:publication_date>2026-11-04T17:39:27Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://nxtin.health/2026/11/04/e20m-to-launch-two-pilot-deep-tech-acceleration-hubs-under-the-european-startup-and-scaleup-hubs-pilot/</loc>
  <lastmod>2026-11-04T19:17:32Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>NXTin health</news:name>
    <news:language>en</news:language>
   </news:publication>
   <news:title>€20M to launch two pilot deep-tech acceleration hubs under the European Startup and Scaleup Hubs Pilot</news:title>
   <news:publication_date>2026-11-04T17:15:00Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://nxtin.health/2026/11/04/drug-precursors-meps-back-tighter-controls-while-protecting-legitimate-trade/</loc>
  <lastmod>2026-11-04T16:56:44Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>NXTin health</news:name>
    <news:language>en</news:language>
   </news:publication>
   <news:title>Drug precursors: MEPs back tighter controls while protecting legitimate trade</news:title>
   <news:publication_date>2026-11-04T16:56:41Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://nxtin.health/2026/11/04/vitola-clinic-is-the-first-in-latvia-to-introduce-robotic-assisted-surgery-in-urology-and-gynaecology/</loc>
  <lastmod>2026-11-04T16:44:19Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>NXTin health</news:name>
    <news:language>en</news:language>
   </news:publication>
   <news:title>Vītola Clinic is the first in Latvia to introduce robotic-assisted surgery in urology and gynaecology</news:title>
   <news:publication_date>2026-11-04T16:44:16Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://nxtin.health/2026/11/04/pauls-stradins-clinical-university-hospital-helps-develop-and-test-a-european-intensive-care-data-system/</loc>
  <lastmod>2026-11-04T16:35:38Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>NXTin health</news:name>
    <news:language>en</news:language>
   </news:publication>
   <news:title>Pauls Stradins Clinical University Hospital helps develop and test a European intensive care data system</news:title>
   <news:publication_date>2026-11-04T16:35:36Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://nxtin.health/2026/11/04/u-s-patent-granted-for-thestras-eplin-as-a-biomarker-for-cancer/</loc>
  <lastmod>2026-11-04T17:43:56Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>NXTin health</news:name>
    <news:language>en</news:language>
   </news:publication>
   <news:title>U.S. patent granted for Thestra´s Eplin as a biomarker for cancer</news:title>
   <news:publication_date>2026-11-04T15:42:00Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://nxtin.health/2026/11/04/from-industrial-electronics-for-weaving-machines-to-medtech-a-natural-extension/</loc>
  <lastmod>2026-11-04T14:13:07Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>NXTin health</news:name>
    <news:language>en</news:language>
   </news:publication>
   <news:title>From industrial electronics for weaving machines to MedTech – a natural extension</news:title>
   <news:publication_date>2026-11-04T07:53:00Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://nxtin.health/2026/11/04/orion-pharma-invests-in-strengthening-pharmaceutical-manufacturing-across-four-finland-locations/</loc>
  <lastmod>2026-11-04T06:26:25Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>NXTin health</news:name>
    <news:language>en</news:language>
   </news:publication>
   <news:title>Orion Pharma invests in strengthening pharmaceutical manufacturing across four Finland locations</news:title>
   <news:publication_date>2026-11-04T06:26:23Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://nxtin.health/2026/11/04/enterprise-ireland-establishes-healthcare-innovation-partnership-with-us-provider/</loc>
  <lastmod>2026-11-04T06:17:55Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>NXTin health</news:name>
    <news:language>en</news:language>
   </news:publication>
   <news:title>Enterprise Ireland establishes healthcare innovation partnership with US provider</news:title>
   <news:publication_date>2026-11-04T06:17:53Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://nxtin.health/2026/11/04/modern-oncology-a-polish-glp-1-medicine-and-a-new-standard-in-diagnostics-six-projects-receive-funding-in-the-abm-competition/</loc>
  <lastmod>2026-11-04T06:11:39Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>NXTin health</news:name>
    <news:language>en</news:language>
   </news:publication>
   <news:title>Modern oncology, a Polish GLP-1 medicine and a new standard in diagnostics: six projects receive funding in the ABM competition</news:title>
   <news:publication_date>2026-11-04T06:11:25Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://nxtin.health/2026/11/04/celon-pharma-qualifies-for-pln-33-9-million-in-funding-for-myasthenia-gravis-drug-development/</loc>
  <lastmod>2026-11-04T06:04:25Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>NXTin health</news:name>
    <news:language>en</news:language>
   </news:publication>
   <news:title>Celon Pharma qualifies for PLN 33.9 million in funding for myasthenia gravis drug development</news:title>
   <news:publication_date>2026-11-04T06:04:23Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://nxtin.health/2026/11/04/fundeni-clinical-institute-receives-award-for-medical-digitalisation-and-innovation/</loc>
  <lastmod>2026-11-04T05:50:38Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>NXTin health</news:name>
    <news:language>en</news:language>
   </news:publication>
   <news:title>Fundeni Clinical Institute receives award for medical digitalisation and innovation</news:title>
   <news:publication_date>2026-11-04T05:50:36Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://nxtin.health/2026/11/03/surgeons-remove-an-11-cm-tumour-growing-inside-the-heart/</loc>
  <lastmod>2026-11-03T16:04:42Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>NXTin health</news:name>
    <news:language>en</news:language>
   </news:publication>
   <news:title>Surgeons remove an 11 cm tumour growing inside the heart</news:title>
   <news:publication_date>2026-11-03T16:04:39Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://nxtin.health/2026/11/03/exogenus-therapeutics-leads-a-e13-million-eu-funded-consortium-to-advance-a-new-secretome-based-therapy-for-osteoarthritis/</loc>
  <lastmod>2026-11-03T15:51:33Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>NXTin health</news:name>
    <news:language>en</news:language>
   </news:publication>
   <news:title>Exogenus Therapeutics leads a €13 million EU-funded consortium to advance a new secretome-based therapy for osteoarthritis</news:title>
   <news:publication_date>2026-11-03T15:50:30Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://nxtin.health/2026/11/03/ehds-stakeholder-forum/</loc>
  <lastmod>2026-11-03T13:27:38Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>NXTin health</news:name>
    <news:language>en</news:language>
   </news:publication>
   <news:title>EHDS Stakeholder forum</news:title>
   <news:publication_date>2026-11-03T13:27:24Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://nxtin.health/2026/11/03/4tissue-raises-e7-million-in-series-a-financing-and-appoints-stephanie-dupont-as-ceo/</loc>
  <lastmod>2026-11-03T11:02:56Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>NXTin health</news:name>
    <news:language>en</news:language>
   </news:publication>
   <news:title>4Tissue raises €7 million in Series A financing and appoints Stéphanie Dupont as CEO</news:title>
   <news:publication_date>2026-11-03T11:01:05Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://nxtin.health/2026/11/03/a-first-for-the-h-u-b-a-heart-transplant-on-a-patient-with-al-amyloidosis/</loc>
  <lastmod>2026-11-03T10:21:21Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>NXTin health</news:name>
    <news:language>en</news:language>
   </news:publication>
   <news:title>A first for the H.U.B: a heart transplant on a patient with AL amyloidosis ​</news:title>
   <news:publication_date>2026-11-03T10:20:05Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://nxtin.health/2026/11/03/the-techmed-event-hospital-of-the-future/</loc>
  <lastmod>2026-11-03T10:09:37Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>NXTin health</news:name>
    <news:language>en</news:language>
   </news:publication>
   <news:title>The TechMed event: Hospital of the future</news:title>
   <news:publication_date>2026-11-03T10:09:35Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://nxtin.health/2026/11/03/transpharmation-ltd-announces-strategic-acquisition-of-organotherapeutics-sarl/</loc>
  <lastmod>2026-11-03T09:01:33Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>NXTin health</news:name>
    <news:language>en</news:language>
   </news:publication>
   <news:title>Transpharmation Ltd. announces strategic acquisition of OrganoTherapeutics SARL</news:title>
   <news:publication_date>2026-11-03T09:01:30Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://nxtin.health/2026/11/03/the-lns-expands-its-capacity-and-strengthens-its-medical-team-in-clinical-genetics/</loc>
  <lastmod>2026-11-03T08:40:45Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>NXTin health</news:name>
    <news:language>en</news:language>
   </news:publication>
   <news:title>The LNS expands its capacity and strengthens its medical team in clinical genetics</news:title>
   <news:publication_date>2026-11-03T08:40:43Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://nxtin.health/2026/11/03/pnoe-cyprus-launches-its-first-participatory-epidemiological-surveillance-network/</loc>
  <lastmod>2026-11-03T08:31:53Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>NXTin health</news:name>
    <news:language>en</news:language>
   </news:publication>
   <news:title>PNOE: Cyprus launches its first participatory epidemiological surveillance network</news:title>
   <news:publication_date>2026-11-03T08:27:24Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://nxtin.health/2026/11/03/digital-assistant-for-doctors-goes-live-in-greeces-national-electronic-health-record-bringing-ai-into-healthcare/</loc>
  <lastmod>2026-11-03T08:13:14Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>NXTin health</news:name>
    <news:language>en</news:language>
   </news:publication>
   <news:title>Digital Assistant for Doctors goes live in Greece&amp;#039;s National Electronic Health Record, bringing AI into healthcare</news:title>
   <news:publication_date>2026-11-03T08:13:12Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://nxtin.health/2026/11/03/minister-katya-ivkova-to-young-health-ambassadors-you-are-the-future-health-diplomats-and-the-pride-of-bulgaria/</loc>
  <lastmod>2026-11-03T08:02:18Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>NXTin health</news:name>
    <news:language>en</news:language>
   </news:publication>
   <news:title>Minister Katya Ivkova to young Health Ambassadors: “You are the future health diplomats and the pride of Bulgaria”</news:title>
   <news:publication_date>2026-11-03T08:00:16Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://nxtin.health/2026/11/02/slovak-ministry-of-economy-launches-e15-million-funding-call-to-support-innovation/</loc>
  <lastmod>2026-11-02T07:56:02Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>NXTin health</news:name>
    <news:language>en</news:language>
   </news:publication>
   <news:title>Slovak Ministry of Economy launches €15 million funding call to support innovation</news:title>
   <news:publication_date>2026-11-02T07:56:00Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://nxtin.health/2026/11/02/european-investment-fund-visits-iocb-prague-to-discuss-support-for-biotech-startups/</loc>
  <lastmod>2026-11-02T07:45:45Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>NXTin health</news:name>
    <news:language>en</news:language>
   </news:publication>
   <news:title>European investment fund visits IOCB Prague to discuss support for biotech startups</news:title>
   <news:publication_date>2026-11-02T07:40:46Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://nxtin.health/2026/11/02/rakathon-2026-showed-how-czech-talent-and-ai-can-help-fight-cancer/</loc>
  <lastmod>2026-11-02T07:30:45Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>NXTin health</news:name>
    <news:language>en</news:language>
   </news:publication>
   <news:title>Rakathon 2026 showed how Czech talent and AI can help fight cancer</news:title>
   <news:publication_date>2026-11-02T07:30:42Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://nxtin.health/2026/11/02/occupational-therapy-helps-oncology-patients-maintain-and-regain-independence/</loc>
  <lastmod>2026-11-03T07:53:06Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>NXTin health</news:name>
    <news:language>en</news:language>
   </news:publication>
   <news:title>Occupational therapy helps oncology patients maintain and regain independence</news:title>
   <news:publication_date>2026-11-02T07:16:41Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://nxtin.health/2026/11/02/astrazeneca-and-oracle-launch-global-ai-collaboration-to-advance-clinical-trial-optimisation-and-support-better-patient-outcomes/</loc>
  <lastmod>2026-11-03T10:39:33Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>NXTin health</news:name>
    <news:language>en</news:language>
   </news:publication>
   <news:title>AstraZeneca and Oracle launch global AI collaboration to advance clinical trial optimisation and support better patient outcomes</news:title>
   <news:publication_date>2026-11-02T07:00:46Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://nxtin.health/2026/11/02/germanys-attractive-healthcare-investment-scene-giants-plans-and-tough-choices/</loc>
  <lastmod>2026-11-01T12:46:59Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>NXTin health</news:name>
    <news:language>en</news:language>
   </news:publication>
   <news:title>Germany’s attractive healthcare investment scene: Giants, plans and tough choices</news:title>
   <news:publication_date>2026-11-02T00:14:00Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
</urlset>
